Antitumor activity of HDAC inhibition in bladder cancer mouse models correlates with enhanced immune response

被引：0
|
作者：
Stewart, Kyle G. [1 ]
Truong, Andrew S. [1 ]
Krishnan, Bhavani [1 ]
Zhou, Mi [1 ]
Saito, Ryoichi [1 ]
Kardos, Jordan [1 ]
Manocha, Ujjawal [1 ]
Bailey, Sean T. [1 ]
Kim, William Y. [1 ]
机构：
[1] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-2748
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2748
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Induction of antitumor immune response by selective HDAC6 inhibition
    Ripamonti, Chiara
    Caprini, Gianluca
    Stevenazzi, Andrea
    Vergani, Barbara
    Aurisicchio, Luigi
    Palombo, Fabio
    Conforti, Antonella
    Steinkuhler, Christian
    Fossati, Gianluca
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [2] Inhibition of HDAC6 enhanced radiation therapy induced antitumor response in melanoma
    Li, Xintang
    Suresh, Manasa
    Coulibaly, Hawa
    Quiceno-Torres, David
    Gajendran, Nithya
    Tan, Karen
    Noonepalle, Satish
    Grindrod, Scott
    Dritschilo, Anatoly
    Villagra, Alejandro
    CANCER RESEARCH, 2024, 84 (06)
  • [3] SYNERGISTIC ANTITUMOR ACTIVITY OF PI3K INHIBITION AND IMMUNE CHECKPOINT BLOCKADE IN BLADDER CANCER
    D'Andrea, Vincent
    Pan, Chong-Xian
    Garisto, Juan D.
    JOURNAL OF UROLOGY, 2023, 209 : E187 - E187
  • [4] Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response
    DuPage, Michel
    Jacks, Tyler
    CURRENT OPINION IN IMMUNOLOGY, 2013, 25 (02) : 192 - 199
  • [5] Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models
    Guo, Zhiqiang
    Li, Yan
    Zhang, Dandan
    Ma, Jiaying
    ONCOTARGET, 2017, 8 (52) : 89761 - 89774
  • [6] Evaluation of the Antitumor Activity of Dacomitinib in Models of Human Bladder Cancer
    Grivas, Petros D.
    Day, Kathleen C.
    Karatsinides, Andreas
    Paul, Alyssa
    Shakir, Nazia
    Owainati, Iya
    Liebert, Monica
    Kunju, Lakshmi P.
    Thomas, Dafydd
    Hussain, Maha
    Day, Mark L.
    MOLECULAR MEDICINE, 2013, 19 : 367 - 376
  • [7] Evaluation of the Antitumor Activity of Dacomitinib in Models of Human Bladder Cancer
    Petros D. Grivas
    Kathleen C. Day
    Andreas Karatsinides
    Alyssa Paul
    Nazia Shakir
    Iya Owainati
    Monica Liebert
    Lakshmi P. Kunju
    Dafydd Thomas
    Maha Hussain
    Mark L. Day
    Molecular Medicine, 2013, 19 : 367 - 376
  • [8] Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
    Zhu, Shaoming
    Ma, A-Hong
    Zhu, Zheng
    Adib, Elio
    Rao, Ting
    Li, Na
    Ni, Kaiyuan
    Chittepu, Veera Chandra Sekhar Reddy
    Prabhala, Rao
    Risco, Juan Garisto
    Kwiatkowski, David
    Mouw, Kent
    Sonpavde, Guru
    Cheng, Fan
    Pan, Chong-Xian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (11)
  • [9] SYNERGISTIC ANTITUMOR ACTIVITY OF PAN-PI3K INHIBITION AND IMMUNE CHECKPOINT BLOCKADE IN BLADDER CANCER
    Pan, C.
    Zhu, Z.
    Zhu, S.
    Ma, A.
    Chittepu, V. C. S. R.
    Farrukh, H.
    Cheng, F.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A2 - A3
  • [10] Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition
    Noonepalle, Satish Kumar R.
    Grindrod, Scott
    Aghdam, Nima
    Li, Xintang
    Gracia-Hernandez, Maria
    Zevallos-Delgado, Christian
    Jung, Mira
    Villagra, Alejandro
    Dritschilo, Anatoly
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12) : 1376 - 1389
12345